{
    "Trade/Device Name(s)": [
        "Prodigy Blood Glucose Test System"
    ],
    "Submitter Information": "Diagnostic Devices, Inc.",
    "510(k) Number": "K053593",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042005"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA",
        "JJX"
    ],
    "Summary Letter Date": "June 12, 2006",
    "Summary Letter Received Date": "June 14, 2006",
    "Submission Date": "December 21, 2005",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Quality control material, assayed and unassayed"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole blood",
        "Control solution"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Prodigy Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical method",
        "Dry reagent biosensor"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Prodigy Blood Glucose Test System using electrochemical method for quantitative glucose measurement in whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in capillary whole blood from the fingertip by people with diabetes at home or by healthcare professionals to monitor effectiveness of diabetes control; not for diagnosis or screening of diabetes, nor for neonates.",
    "fda_folder": "Clinical Chemistry"
}